Human papillomavirus testing in primary cervical screening
- 1 June 1995
- journal article
- Published by Elsevier in The Lancet
- Vol. 345 (8964), 1533-1536
- https://doi.org/10.1016/s0140-6736(95)91086-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significanceAmerican Journal of Obstetrics and Gynecology, 1995
- Screening for cervical neoplasia in Dundee and Angus 10 years onBJOG: An International Journal of Obstetrics and Gynaecology, 1995
- Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potentialInternational Journal of Cancer, 1995
- Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasiaBritish Journal of Cancer, 1994
- Audit of deaths from cervical cancer: proposal for an essential component of the National Screening Programme.Journal of Clinical Pathology, 1994
- Rationale for stopping cervical screening in women over 50.BMJ, 1993
- Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear reportBritish Journal of Cancer, 1993
- A Cohort Study of the Risk of Cervical Intraepithelial Neoplasia Grade 2 or 3 in Relation to Papillomavirus InfectionNew England Journal of Medicine, 1992
- Human papillomavirus type 16 DNA in cervical smears as predictor of high-grade cervical cancerThe Lancet, 1992
- Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection?American Journal of Obstetrics and Gynecology, 1991